New cocktail of drugs aims to shrink Hard-to-Treat abdominal tumors
Disease control
Not yet recruiting
This Phase 2 trial tests whether adding pirfenidone and sintilimab to standard chemotherapy can shrink tumors in 30 people with colorectal cancer that has spread to the lining of the abdomen. Participants will receive the drug combination before any other treatment. The study wil…
Phase: PHASE2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC